November 2011 - IOZK

Anti-leukemic activity of Newcastle disease virus strains AF2240 and V4-UPM in murine myelomonocytic leukemia in vivo

2011-11-30/in Acute Leukemia, International Publications, Newcastle Disease Virus

The roles of tumor-derived exosomes in cancer pathogenesis

2011-11-30/in Exosome, International Publications

Development of sipuleucel-T: autologous cellular immunotherapy for the treatment of metastatic castrate resistant prostate cancer

2011-11-26/in Dendritic Cells, International Publications, Prostate Cancer

Therapeutical doses of temozolomide do not impair the function of dendritic cells and CD8+ T cells

2011-11-23/in Dendritic Cells, Glioblastoma, International Publications

Newcastle disease virus induces pro-inflammatory conditions and type I interferon for counter-acting Treg activity

2011-11-16/in International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus

Vaccination with dendritic cells loaded with tumor apoptotic bodies (Apo-DC) in patients with chronic lymphocytic leukemia: effects of various adjuvants and definition of immune response criteria

2011-11-16/in Chronic Leukemia, Dendritic Cells, International Publications

Newcastle disease virus induces apoptosis in cisplatin-resistant human lung adenocarcinoma A549 cells in vitro and in vivo

2011-11-15/in International Publications, Newcastle Disease Virus, NSCLC

Adjuvant immunotherapy with whole-cell lysate dendritic cells vaccine for glioblastoma multiforme: a phase II clinical trial

2011-11-07/in Dendritic Cells, Glioblastoma, International Publications

Pilot clinical trial of type 1 dendritic cells loaded with autologous tumor lysates combined with GM-CSF, pegylated IFN, and cyclophosphamide for metastatic cancer patients

2011-11-02/in Dendritic Cells, International Publications

Long-term vaccine therapy with autologous whole tumor cell-pulsed dendritic cells for a patient with recurrent rectal carcinoma

2011-11-01/in Colorectal Cancer, Dendritic Cells, International Publications